Assessment of efficacy and safety profile of irbesartan/amlodipine single-pill combination drug in uncontrolled-hypertension with type 2 diabetic patients.
Not Applicable
- Conditions
- Hypertension with type 2 diabetes
- Registration Number
- JPRN-UMIN000010266
- Lead Sponsor
- Kanazawa Medical University Diabetes and Endocrinology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
The exclusion criteria are based on fulfillment of at least one of the following; 1) a past history of allergy of this medicine or dihydropyridine drugs; 2) pregnancy, possibility of pregnancy; 3) current treatment with corticosteroids and/or immnosuppressive drugs; 4) patients who judge that the physician is not suitable
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method